{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:55:16Z","timestamp":1794135316574,"version":"4.8.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006461","name":"Agencia de Innovaci\u00f3n y Desarrollo de Andaluc\u00eda","doi-asserted-by":"publisher","award":["B63C22001470005"],"award-info":[{"award-number":["B63C22001470005"]}],"id":[{"id":"10.13039\/501100006461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006461","name":"Agencia de Innovaci\u00f3n y Desarrollo de Andaluc\u00eda","doi-asserted-by":"publisher","award":["NRR-MAD-2022-12376723"],"award-info":[{"award-number":["NRR-MAD-2022-12376723"]}],"id":[{"id":"10.13039\/501100006461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["29187 CUP G43C23002760007"],"award-info":[{"award-number":["29187 CUP G43C23002760007"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109085","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T03:53:51Z","timestamp":1760500431000},"page":"109085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells"],"prefix":"10.1016","volume":"166","author":[{"given":"Ilaria","family":"Cursaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Frattaruolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Scalvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Contri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Bichicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tardiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia Nicol","family":"Manti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Papulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Maellaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Marcolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Altucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Varani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Frosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Lodola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Saponara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Butini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Carullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Campiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109085_bb0005","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1021\/acschemneuro.0c00358","article-title":"Retinitis Pigmentosa and retinal degenerations: deciphering pathways and targets for drug discovery and development","volume":"11","author":"Carullo","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2025.109085_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710014","article-title":"A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors","volume":"23","author":"Fontana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109085_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116537","article-title":"A novel potent class I HDAC inhibitor reverses the STAT4\/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients","volume":"174","author":"Rossi","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.109085_bb0020","article-title":"Novel quinolone-based potent and selective HDAC6 inhibitors: synthesis, molecular modeling studies and biological investigation","volume":"90","author":"Relitti","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0025","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1021\/acsptsci.4c00208","article-title":"Development of epigenetic modifiers with therapeutic potential in FMS-related tyrosine kinase 3\/internal tandem duplication (FLT3\/ITD) acute myeloid leukemia and other blood malignancies","volume":"7","author":"Carullo","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.bioorg.2025.109085_bb0030","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty Years of HDAC Inhibitors: 2020 Insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01643-6","article-title":"The application of histone deacetylases inhibitors in glioblastoma","volume":"39","author":"Chen","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109085_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.578770","article-title":"Histone deacetylases and histone deacetylase inhibitors in neuroblastoma","volume":"8","author":"Phimmachanh","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2025.109085_bb0045","doi-asserted-by":"crossref","unstructured":"J.Y.; Kim, H.; Cho, J.; Yoo, G.W.; Kim, Y.H.; Jeon, S.W.; Lee, Y. Li, K. Deka, J.Y. Kim, H. Cho, J. Yoo, W. Kim, Y.H. Jeon, S.W. Lee, S.H. Kwon, Pathological Role of HDAC8: Cancer and Beyond, Cells 2022, Vol. 11, Page 3161 11 (2022) 3161. doi: https:\/\/doi.org\/10.3390\/CELLS11193161.","DOI":"10.3390\/cells11193161"},{"key":"10.1016\/j.bioorg.2025.109085_bb0050","doi-asserted-by":"crossref","unstructured":"L. Zhang, Y. Yang, Y. Li, C. Wang, C. Bian, H. Wang, F. Wang, Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights, Biomarker Research 2025 13:1 13 (2025) 1\u201332. doi: https:\/\/doi.org\/10.1186\/S40364-025-00788-W.","DOI":"10.1186\/s40364-025-00788-w"},{"key":"10.1016\/j.bioorg.2025.109085_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106921","article-title":"Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity","volume":"203","author":"Cho","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.109085_bb0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.18632\/genesandcancer.197","article-title":"Hdac8 affects mgmt levels in glioblastoma cell lines via interaction with the proteasome receptor adrm1","volume":"10","author":"Santos-Barriopedro","year":"2019","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bioorg.2025.109085_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1515\/med-2018-0034","article-title":"Growth suppression of glioma cells using HDAC6 inhibitor, tubacin","volume":"13","author":"Yin","year":"2018","journal-title":"Open Medicine (Poland)"},{"key":"10.1016\/j.bioorg.2025.109085_bb0070","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3390\/molecules21111608","article-title":"Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer","volume":"21","author":"Losson","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109085_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400682","article-title":"Targeting N-methyl-lysine histone demethylase KDM4 in Cancer: natural products inhibitors as a driving force for epigenetic drug discovery","volume":"20","author":"Cursaro","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109085_bb0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00210-023-02674-4","article-title":"Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents","volume":"397","author":"Wahi","year":"2023","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109085_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bcp.2015.11.005","article-title":"4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90\u03b1 chaperone activity against prostate cancer","volume":"99","author":"Seidel","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109085_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-13-232","article-title":"Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: Sinapinic acid acts as HDAC inhibitor","volume":"13","author":"Senawong","year":"2013","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.bioorg.2025.109085_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.phrs.2017.11.004","article-title":"Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways","volume":"129","author":"Lernoux","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.109085_bb0100","doi-asserted-by":"crossref","first-page":"S645","DOI":"10.4103\/pm.pm_389_16","article-title":"Cinnamaldehyde, cinnamic acid, and cinnamyl alcohol, the bioactives of Cinnamomum cassia exhibit HDAC8 inhibitory activity: an in vitro and in silico study","volume":"13","author":"Patil","year":"2017","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.bioorg.2025.109085_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2021.106588","article-title":"Matairesinol, an active constituent of HC9 polyherbal formulation, exhibits HDAC8 inhibitory and anticancer activity","volume":"273","author":"Mahajan","year":"2021","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9111077","article-title":"New oleoyl hybrids of natural antioxidants: synthesis and in vitro evaluation as inducers of apoptosis in colorectal cancer cells","volume":"9","author":"Carullo","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioorg.2025.109085_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114274","article-title":"Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy","volume":"235","author":"Campiani","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200050","article-title":"Design and synthesis of Oligopeptidic Parvulin inhibitors","volume":"17","author":"Relitti","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109085_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300270","article-title":"Development of 1-(2-aminophenyl)pyrrole-based amides acting as human topoisomerase I inhibitors","volume":"356","author":"Carullo","year":"2023","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.109085_bb0130","doi-asserted-by":"crossref","first-page":"8634","DOI":"10.1021\/acs.jmedchem.0c01025","article-title":"Characterization of Conformationally constrained Benzanilide scaffolds for potent and selective HDAC8 targeting","volume":"63","author":"Hassan","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0135","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/ml4002908","article-title":"Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and Biological Investigation","volume":"4","author":"Butini","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109085_bb0140","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejmech.2017.06.017","article-title":"First dual AK\/GSK-3\u03b2 inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents","volume":"138","author":"Brogi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0145","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/cmdc.201600111","article-title":"TRPV1\u2013FAAH\u2013COX: the couples game in pain treatment","author":"Aiello","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109085_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114429","article-title":"A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: role of CaV1.2 and KCa1.1 channels","volume":"185","author":"Carullo","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109085_bb0155","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ejmech.2017.10.076","article-title":"The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6\/HDAC8 selectivity","volume":"143","author":"Negmeldin","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114409","article-title":"Azetidin-2-one-based small molecules as dual hHDAC6\/HDAC8 inhibitors: investigation of their mechanism of action and impact of dual inhibition profile on cell viability","volume":"238","author":"Federico","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300410","article-title":"Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents","volume":"356","author":"Papa","year":"2023","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.109085_bb0170","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c00477","article-title":"Targeting relevant HDACs to support the survival of cone photoreceptors in inherited retinal diseases: identification of a potent pharmacological tool with in vitro and in vivo efficacy","author":"Carullo","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0175","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/jm400390r","article-title":"Discovery of the first histone deacetylase 6\/8 dual inhibitors","volume":"56","author":"Olson","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0180","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/jm701247k","article-title":"Clotrimazole Scaffold as an Innovative Pharmacophore Towards Potent Antimalarial Agents: Design, Synthesis, and Biological and Structure\u2013Activity Relationship Studies","volume":"51","author":"Gemma","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127023","article-title":"Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6","volume":"30","author":"Osko","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109085_bb0190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.109085_bb0195","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1073\/pnas.1718823114","article-title":"Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors","volume":"114","author":"Porter","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109085_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116085","article-title":"Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors","volume":"35","author":"Tavares","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-023-00798-0","article-title":"Effects of HDAC inhibitors on neuroblastoma SH-SY5Y cell differentiation into mature neurons via the Wnt signaling pathway","volume":"24","author":"Choi","year":"2023","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bioorg.2025.109085_bb0210","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/jcb.24491","article-title":"HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells","volume":"114","author":"Jin","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120024","article-title":"N-acetyl l-aspartate and Triacetin modulate tumor suppressor MicroRNA and class I and II HDAC gene expression induce apoptosis in glioblastoma cancer cells in vitro","volume":"286","author":"Mekala","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.109085_bb0220","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1158\/1078-0432.CCR-07-5023","article-title":"The double-edged sword of autophagy modulation in cancer","volume":"15","author":"White","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109085_bb0225","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1073\/pnas.1204429109","article-title":"Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death","volume":"109","author":"Gammoh","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109085_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109085_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-2586-x","article-title":"Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma","volume":"11","author":"Auzmendi-Iriarte","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.109085_bb0240","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/ijc.23243","article-title":"Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer","volume":"122","author":"Qian","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.109085_bb0245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11060-011-0604-7","article-title":"Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures","volume":"105","author":"Xu","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bioorg.2025.109085_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394387-3.00001-X","article-title":"Histone deacetylase inhibitors disrupt the mitotic spindle assembly checkpoint by targeting histone and nonhistone proteins","volume":"116","author":"Gabrielli","year":"2012","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109085_bb0255","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.onc.1210779","article-title":"Histone deacetylase inhibitors induce mitotic slippage","volume":"27","author":"Stevens","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.109085_bb0260","doi-asserted-by":"crossref","first-page":"W469","DOI":"10.1093\/nar\/gkae254","article-title":"Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction","volume":"52","author":"Myung","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.109085_bb0265","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1158\/1078-0432.CCR-09-1039","article-title":"Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks","volume":"15","author":"Palmieri","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109085_bb0270","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1158\/1078-0432.CCR-12-1841","article-title":"Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: north american brain tumor consortium study 04-03","volume":"18","author":"Lee","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109085_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-00953-2","article-title":"Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients","volume":"8","author":"Guntner","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bioorg.2025.109085_bb0280","doi-asserted-by":"crossref","first-page":"18577","DOI":"10.18632\/oncotarget.14612","article-title":"Advances in epigenetic glioblastoma therapy","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.109085_bb0285","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ejmech.2016.10.064","article-title":"Identification of novel fluorescent probes preventing PrPSc replication in prion diseases","volume":"127","author":"Zaccagnini","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109085_bb0290","unstructured":"Life Science: MacroModel - Schr\u00f6dinger, (n.d.). https:\/\/newsite.schrodinger.com\/platform\/products\/macromodel\/ (accessed March 2, 2024)."},{"key":"10.1016\/j.bioorg.2025.109085_bb0295","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2025.109085_bb0305","unstructured":"Glide \u2014 glide v0.9.1, (2025). https:\/\/hexdocs.pm\/glide\/Glide.html (accessed June 4, 2025)."},{"key":"10.1016\/j.bioorg.2025.109085_bb0310","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/antiox11010081","article-title":"Acacia catechu willd. Extract protects neuronal cells from oxidative stress-induced damage","volume":"11","author":"Chiaino","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioorg.2025.109085_bb0315","article-title":"Spirotetrahydroisoquinoline-based histone deacetylase inhibitors as new Antifibrotic agents: biological evaluation in human fibroblasts from Bronchoalveolar lavages of idiopathic pulmonary fibrosis patients","author":"Fontana","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.bioorg.2025.109085_bb0320","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1002\/jcp.27838","article-title":"Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: a role for autophagy and premature senescence","volume":"234","author":"Allavena","year":"2019","journal-title":"J. Cell. Physiol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:55:51Z","timestamp":1766098551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":63,"alternative-id":["S0045206825009654"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109085","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109085"}}